Cargando…
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838672/ https://www.ncbi.nlm.nih.gov/pubmed/35276984 http://dx.doi.org/10.3390/nu14030625 |
_version_ | 1784650183901970432 |
---|---|
author | Szklener, Katarzyna Szklener, Sebastian Michalski, Adam Żak, Klaudia Kuryło, Weronika Rejdak, Konrad Mańdziuk, Sławomir |
author_facet | Szklener, Katarzyna Szklener, Sebastian Michalski, Adam Żak, Klaudia Kuryło, Weronika Rejdak, Konrad Mańdziuk, Sławomir |
author_sort | Szklener, Katarzyna |
collection | PubMed |
description | Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered particularly challenging, with this condition often being perceived as very difficult or even impossible to prevent with currently available agents. Therefore, it is imperative to find better options for patients diagnosed with this condition. While the search for the new agents must continue, another opportunity should be taken into consideration—repurposing of the already known medications. As proposed, acetyl-L-carnitine, vitamins (group B and E), extracts of medical plants, including goshajinkigan, curcumin and others, unsaturated fatty acids, as well as the diet composed of so-called “sirtuin-activating foods”, could change the typical way of treatment of CIPN, improve the quality of life of patients and maintain the continuity of chemotherapy. This review summarizes currently available data regarding mentioned above agents and evaluates the rationale behind future research focused on their efficacy in CIPN. |
format | Online Article Text |
id | pubmed-8838672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88386722022-02-13 Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? Szklener, Katarzyna Szklener, Sebastian Michalski, Adam Żak, Klaudia Kuryło, Weronika Rejdak, Konrad Mańdziuk, Sławomir Nutrients Review Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered particularly challenging, with this condition often being perceived as very difficult or even impossible to prevent with currently available agents. Therefore, it is imperative to find better options for patients diagnosed with this condition. While the search for the new agents must continue, another opportunity should be taken into consideration—repurposing of the already known medications. As proposed, acetyl-L-carnitine, vitamins (group B and E), extracts of medical plants, including goshajinkigan, curcumin and others, unsaturated fatty acids, as well as the diet composed of so-called “sirtuin-activating foods”, could change the typical way of treatment of CIPN, improve the quality of life of patients and maintain the continuity of chemotherapy. This review summarizes currently available data regarding mentioned above agents and evaluates the rationale behind future research focused on their efficacy in CIPN. MDPI 2022-01-31 /pmc/articles/PMC8838672/ /pubmed/35276984 http://dx.doi.org/10.3390/nu14030625 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Szklener, Katarzyna Szklener, Sebastian Michalski, Adam Żak, Klaudia Kuryło, Weronika Rejdak, Konrad Mańdziuk, Sławomir Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title | Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title_full | Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title_fullStr | Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title_full_unstemmed | Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title_short | Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? |
title_sort | dietary supplements in chemotherapy-induced peripheral neuropathy: a new hope? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838672/ https://www.ncbi.nlm.nih.gov/pubmed/35276984 http://dx.doi.org/10.3390/nu14030625 |
work_keys_str_mv | AT szklenerkatarzyna dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT szklenersebastian dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT michalskiadam dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT zakklaudia dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT kuryłoweronika dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT rejdakkonrad dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope AT mandziuksławomir dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope |